FORMULACIJE (+)-2-[1-(3-ETOKSI-4-METOKSI-FENIL)-2-METANSULFONIL-ETIL]-4-ACETIL AMINOIZOINDOLIN-1,3-DIONA

• 收藏
• 分享

专利权人:

Amgen (Europe) GmbH

发明人:

Bhat, Sreenivas S.,Kelly, Michael T.

申请号：

HRP20200825

公开号：

HRP20200825T1

申请日:

2020.05.21

申请国别(地区):

HR

年份:

2020

代理人:

摘要：

Pharmaceutical compositions and single unit dosage forms of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate thereof, are provided herein. Also provided are methods of treating, managing, or preventing various diseases or disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/